Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 2 member 14 (SLC2A14, also known as GLUT14) is an integral membrane protein that mediates facilitated diffusion of glucose and other hexoses like fructose and dehydroascorbate across the plasma membrane. It is a member of the GLUT family of glucose transporters and is highly conserved. Although it shares functional similarity with other glucose transporters (notably SLC2A3/GLUT3), its expression exhibits tissue specificity and its biological and pathological functions are still being elucidated. Diseases associated with SLC2A14 mutations include arterial tortuosity syndrome and neuronal ceroid lipofuscinosis. No drugs are currently reported to act as direct and selective modulators of SLC2A14 in clinical use
Modulation or inhibition of glucose and hexose transport across cell membranes; mechanisms for drugs would involve blocking or altering transporter activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 2 member 14 (SLC2A14).